Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
- PMID: 33887951
- PMCID: PMC8098652
- DOI: 10.2217/cer-2021-0050
Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
Keywords: COVID-19; clinical trials; tocilizumab.
Similar articles
-
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.Pulmonology. 2021 Jan-Feb;27(1):52-66. doi: 10.1016/j.pulmoe.2020.07.003. Epub 2020 Jul 20. Pulmonology. 2021. PMID: 32713784 Free PMC article.
-
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21. Mult Scler Relat Disord. 2020. PMID: 33296987 Free PMC article.
-
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.N Engl J Med. 2021 Apr 15;384(15):1473. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3. N Engl J Med. 2021. PMID: 33657286 No abstract available.
-
Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials.J Investig Med. 2022 Jan;70(1):55-60. doi: 10.1136/jim-2021-002001. Epub 2021 Sep 24. J Investig Med. 2022. PMID: 34561232 Free PMC article.
-
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615. JAMA Intern Med. 2021. PMID: 33080005 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources